BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 9894849)

  • 1. Multiple transcripts of the killer cell immunoglobulin-like receptor family, KIR3DL1 (NKB1), are expressed by natural killer cells of a single individual.
    Vyas Y; Selvakumar A; Steffens U; Dupont B
    Tissue Antigens; 1998 Dec; 52(6):510-9. PubMed ID: 9894849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor.
    Gumperz JE; Litwin V; Phillips JH; Lanier LL; Parham P
    J Exp Med; 1995 Mar; 181(3):1133-44. PubMed ID: 7532677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneous phenotypes of expression of the NKB1 natural killer cell class I receptor among individuals of different human histocompatibility leukocyte antigens types appear genetically regulated, but not linked to major histocompatibililty complex haplotype.
    Gumperz JE; Valiante NM; Parham P; Lanier LL; Tyan D
    J Exp Med; 1996 Apr; 183(4):1817-27. PubMed ID: 8666938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular cloning of NKB1. A natural killer cell receptor for HLA-B allotypes.
    D'Andrea A; Chang C; Franz-Bacon K; McClanahan T; Phillips JH; Lanier LL
    J Immunol; 1995 Sep; 155(5):2306-10. PubMed ID: 7650366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NKB1: a natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules.
    Litwin V; Gumperz J; Parham P; Phillips JH; Lanier LL
    J Exp Med; 1994 Aug; 180(2):537-43. PubMed ID: 8046332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conserved and variable residues within the Bw4 motif of HLA-B make separable contributions to recognition by the NKB1 killer cell-inhibitory receptor.
    Gumperz JE; Barber LD; Valiante NM; Percival L; Phillips JH; Lanier LL; Parham P
    J Immunol; 1997 Jun; 158(11):5237-41. PubMed ID: 9164941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specificity of two anti-class I HLA monoclonal antibodies that block class I recognition by the NKB1 killer cell inhibitory receptor.
    Gumperz JE; Paterson JC; Litwin V; Valiante N; Lanier LL; Parham P; Little AM
    Tissue Antigens; 1996 Oct; 48(4 Pt 1):278-84. PubMed ID: 8946681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The NKB1 and HP-3E4 NK cells receptors are structurally distinct glycoproteins and independently recognize polymorphic HLA-B and HLA-C molecules.
    Lanier LL; Gumperz JE; Parham P; Melero I; López-Botet M; Phillips JH
    J Immunol; 1995 Apr; 154(7):3320-7. PubMed ID: 7897214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematopoietic stem cell transplantation: Improving alloreactive Bw4 donor selection by genotyping codon 86 of KIR3DL1/S1.
    Alicata C; Pende D; Meazza R; Canevali P; Loiacono F; Bertaina A; Locatelli F; Nemat-Gorgani N; Guethlein LA; Parham P; Moretta L; Moretta A; Bottino C; Norman PJ; Falco M
    Eur J Immunol; 2016 Jun; 46(6):1511-7. PubMed ID: 26990677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional polymorphism of the KIR3DL1/S1 receptor on human NK cells.
    O'Connor GM; Guinan KJ; Cunningham RT; Middleton D; Parham P; Gardiner CM
    J Immunol; 2007 Jan; 178(1):235-41. PubMed ID: 17182560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NK cell natural cytotoxicity and IFN-gamma production are not always coordinately regulated: engagement of DX9 KIR+ NK cells by HLA-B7 variants and target cells.
    Kurago ZB; Lutz CT; Smith KD; Colonna M
    J Immunol; 1998 Feb; 160(4):1573-80. PubMed ID: 9469412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interaction of KIR3DL1*001 with HLA class I molecules is dependent upon molecular microarchitecture within the Bw4 epitope.
    Saunders PM; Vivian JP; Baschuk N; Beddoe T; Widjaja J; O'Connor GM; Hitchen C; Pymm P; Andrews DM; Gras S; McVicar DW; Rossjohn J; Brooks AG
    J Immunol; 2015 Jan; 194(2):781-789. PubMed ID: 25480565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-Bw4 80(T) and multiple HLA-Bw4 copies combined with KIR3DL1 associate with spontaneous clearance of HCV infection in people who inject drugs.
    Thöns C; Senff T; Hydes TJ; Manser AR; Heinemann FM; Heinold A; Heilmann M; Kim AY; Uhrberg M; Scherbaum N; Lauer GM; Khakoo SI; Timm J
    J Hepatol; 2017 Sep; 67(3):462-470. PubMed ID: 28412292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human leukocyte antigens A23, A24, and A32 but not A25 are ligands for KIR3DL1.
    Stern M; Ruggeri L; Capanni M; Mancusi A; Velardi A
    Blood; 2008 Aug; 112(3):708-10. PubMed ID: 18502829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoinformatic docking approach for the analysis of KIR3DL1/HLA-B interaction.
    Grifoni A; Montesano C; Patronov A; Colizzi V; Amicosante M
    Biomed Res Int; 2013; 2013():283805. PubMed ID: 23984333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors.
    Della Chiesa M; Vitale M; Carlomagno S; Ferlazzo G; Moretta L; Moretta A
    Eur J Immunol; 2003 Jun; 33(6):1657-66. PubMed ID: 12778484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different NK cell surface phenotypes defined by the DX9 antibody are due to KIR3DL1 gene polymorphism.
    Gardiner CM; Guethlein LA; Shilling HG; Pando M; Carr WH; Rajalingam R; Vilches C; Parham P
    J Immunol; 2001 Mar; 166(5):2992-3001. PubMed ID: 11207248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro education of human natural killer cells by KIR3DL1.
    Pugh J; Nemat-Gorgani N; Djaoud Z; Guethlein LA; Norman PJ; Parham P
    Life Sci Alliance; 2019 Dec; 2(6):. PubMed ID: 31723004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KIR3DL1 Allelic Polymorphism and HLA-B Epitopes Modulate Response to Anti-GD2 Monoclonal Antibody in Patients With Neuroblastoma.
    Forlenza CJ; Boudreau JE; Zheng J; Le Luduec JB; Chamberlain E; Heller G; Cheung NK; Hsu KC
    J Clin Oncol; 2016 Jul; 34(21):2443-51. PubMed ID: 27069083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Killer cell inhibitory receptors for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells, gamma delta T cells, and antigen-specific CTL.
    Bakker AB; Phillips JH; Figdor CG; Lanier LL
    J Immunol; 1998 Jun; 160(11):5239-45. PubMed ID: 9605119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.